APOA1 and cardiovascular disorder: It has been revealed that As exposure can interfere with apolipoprotein metabolism, resulting in a rise in Apo-B and Apo-B/Apo-A1 ratios, a decrease in Apo-A1, and an elevated risk of acute cardiovascular disease events like myocardial infarction and acute cerebral strokes [36].